Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.

O. Efthymiadou (London, United Kingdom), B. Kamphuis (London, United Kingdom), V. Tzouma (London, United Kingdom), P. Kanavos (London, United Kingdom)

Source: Virtual Congress 2020 – Advances in asthma treatment
Session: Advances in asthma treatment
Session type: E-poster session
Number: 2611
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Efthymiadou (London, United Kingdom), B. Kamphuis (London, United Kingdom), V. Tzouma (London, United Kingdom), P. Kanavos (London, United Kingdom). Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians.. 2611

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018

The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021

Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Late Breaking Abstract - Knowledge, anxiety and use of hydroxychloroquine prophylaxis among healthcare students and professionals regarding COVID-19 pandemic in India: An observational cross-sectional study
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


Severe T2-high asthma in the biologics era: European experts' opinion
Source: Eur Respir Rev, 28 (152) 190054; 10.1183/16000617.0054-2019
Year: 2019



Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021

Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Inappropriate asthma therapy: A tale of two countries
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016

Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Treatment trends for asthma-COPD overlap syndrome patients: Findings from a real world survey
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016


Decision analytic models in COPD/asthma: A critical review of current evidence
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Perception of asthma control by patients: results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007